Login

Healthcare

00:10:00
Journey of Success: Dr. Garo Armen's Inspiring Life and Impact on Science, Entrepreneurship, and Philanthropy |Hartley Atkinson, CEO, AFT Pharmaceuticals Ltd .
00:10:00
Navigating the IPO process, CEO discusses the critical role of his company in healthcare infrastructure and its resilience amidst challenges |Tom Leonard, CEO, Agiliti Inc .
00:10:00
Exploring Agios' Pioneering Approach at the Intersection of Cancer Metabolism and Genomics | Brian Goff, CEO,Agios Pharmaceuticals Inc .
00:10:00
Exploring Innovations, Ethical Ventures, and the Pursuit of Longevity with a Diverse Investor and Advocate | Jim Mellon, CEO, Agronomics Ltd .
00:10:00
Exploring the Future of Cellular Agriculture: Innovations, Implications, and Supermarket Shelves|Jim Mellon, CEO, Agronomics Ltd .
00:10:00
Overview of AIM ImmunoTech's Pancreatic Cancer Program with Promising Follow-On Data Release| Thomas Equels, CEO, AIM ImmunoTech Inc.
00:10:00
Building a Biotech Hub: Insights from an Entrepreneur's Perspective on Boston's Vibrant Ecosystem and the Importance of Physical Space for Team Collaboration|Rachelle Jacques, CEO, Akari Therapeutics PLC.
00:10:00
Navigating the Allergy Therapeutics landscape: Insights into Market Expansion and Financial Strength |Manuel Llobet, CEO, Allergy Therapeutics PLC.
00:10:00
Update on Alligator Bioscience's Clinical Trials and Pipeline Progress, Anticipating Positive Outcomes and Partnership Discussions |Søren Bregenholt, CEO, Alligator Bioscience AB.
00:10:00
Analyzing Allergy Therapeutics' Financial Performance and Promising Developments Amid Record Pre-R&D Operating Profit and Successful Biomarker Study |Manuel Llobet, CEO, Allergy Therapeutics PLC.
00:10:00
Unlocking the Secrets of Human Aging: The Role of Telomeres and Telomerase |Dr. Michael D. West , CEO, AgeX Therapeutics Inc .
00:10:00
Navigating Forward-Looking Statements and Risks in AIM ImmunoTech's Interview| Thomas Equels, CEO, AIM ImmunoTech Inc.
00:10:00
Akari Therapeutics' Innovative Approach to Treating Rare Hematopoietic Stem Cell Transplant Complications| Rachelle Jacques, CEO, Akari Therapeutics PLC.
00:10:00
Exploring Innovations in Cancer Immunotherapy|Søren Bregenholt, CEO, Alligator Bioscience AB.
00:10:00
Exploring Agios' Pioneering Approach at the Intersection of Cancer Metabolism and Genomics | David Schenkein, CEO,Agios Pharmaceuticals Inc .
00:10:00
CEO Discusses Strategic Vision for Environmental, Social, and Governance Initiatives|Gianfranco Nazzi, CEO, Almirall SA.

© 2017 - Townhall + Tv